Patent · US Active

Anticancer agents

US8653283B2 · kind B2 · utility

0Cited by
0References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 16, 2010
Grant dateFeb 18, 2014
Priority date
Expiry dateApr 16, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present disclosure relates generally to compositions and methods for treating cancer. In some aspects, novel spirohexenolides and methods of using and producing them are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.